Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects

Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects




Best Over The counter Sleep Aid 2026: Launched By NooCube Strongest natural sleep aid, Pills For Sleep And Anxiety Without Side effects

Strongest sleep aid over the counter sleep Pills NooCube best for sleep and anxiety read side effects, benefits, ingredients of NooCube supplement

New York City, Jan. 04, 2026 (GLOBE NEWSWIRE) —

In 2026 Getting good sleep is more like a habit that some people cannot make due to hectic lifestyles. Over the counter, sleeping pills aren’t synthetic drugs but natural supplements which we are going to discuss below. 

They do not have side effects like most pharmaceuticals prescription-based sleeping pills available in the pharmacy. Speaking of OTC sleeping pills, NooCube Sleep is the best otc sleeping aid supplement to attain unmatched effectiveness and sleep quality. Click here to visit noocube sleep official website.

Sleep is like charging the battery of humans which gives you enough rest to carry on with the next day. Getting good sleep is closely linked to a healthy life and healthy brain functioning. Those people who take a good night’s sleep regularly tend to be sharp learners, memorizers, and good rapid decision makers because their cognitive skills are just to the point.

Insufficient sleep is associated with many serious and life-threatening diseases such as cardiovascular incidents, obesity, diabetes, and loss of focus or concentration. Sleep is a natural phenomenon that occurs daily but still around 20% of people are unable to get it every night, thus they develop occasional symptoms of insomnia.

Studies by the National Sleep Foundation show that sleep problems are more commonly reported now than ever before, so it should be no surprise that demand for sleeping medications is at an all time high. There are some people dealing with sleep issues that still find themselves asking are sleeping pills safe though.

A lot of this confusion comes from a lack of understanding on the difference between prescription drugs and over the counter sleep aids. While both can be used to treat severe insomnia patients, that latter is undoubtedly much safer and a far better choice for people who just have a little trouble falling asleep.

That is why we have created our guide to the best OTC sleep aids and prescription sleep medications. This will give you all of the information that you need to choose the perfect sleep aid to help combat any sleep disorder, optimise your sleep wake cycle, or simply just improve sleep habits, no matter your own situation.

Best Sleeping Pills Over the Counter

The thing about OTC medicines is they can be purchased without a prescription and most of them are sold in every pharmacy nearby. OTC medications can also be found in many supermarkets and drug stores since they don’t require direct FDA approval, however, the active ingredient must be FDA-approved. Click here to read more about sleeping pills online

FDA is responsible for the streaming of the best sleeping pills in the market and also their distribution takes place in the right hand.

There are countless brands of the counter sleeping pills most of which are antihistamines that are used against allergies. Since allergy medication induces drowsiness, this made them used as OTC sleeping aid.

Best Over the Counter Sleeping Pills

OTC sleeping aids are preferred over sleeping drugs because OTC versions improve the overall sleep experiences of the users.

Melatonin is put in most natural sleep aids as studies on behavioral sleep medicine show it is among the very best ways to help you sleep. However, some people avoid it as it can cause side effects like nightmares or frequent urination in certain people, making it even harder to sleep.

NooCube Sleep Upgrade is one of the most popular natural sleep aids for people in this group, as it specifically omits melatonin from its formula.

It instead contains:

  • Magnesium
  • Calcium
  • Vitamin d
  • Lemon balm leaf powder
  • Lavender extract

Sleeping aids for which you don’t need a prescription and are available over the counter are:

      1.   Melatonin

Melatonin is a natural hormone produced by the body to make it sleep. The hormone makes signaling to the brain that it’s time to sleep, however, in sleep-deficient people the levels of melatonin are greatly reduced. Melatonin production and release depends on the time of the day, typically it increases naturally in the evening and falls in the morning.

Melatonin supplements are popular sleeping aid in 2026 and are mainly used by individuals having an impaired melatonin cycle. In many studies, a connection was established between melatonin production and daytime sleep quality. Men and women such as shift workers whose schedule requires them to sleep during the daytime.

Melatonin does not just improve sleep quality but it can also mend fewer sleep disorders. The compound reduces the time people need to fall asleep or in other words, sleep latency, and it increases the total amount of time you sleep.

      2.   Valerian Root

Searching for the best OTC sleeping pills, you may always find valerian root which is a common treatment for anxiety, depression, and menopause symptoms. In US, Europe, and Asia, Valerian Root supplements are the most common sleeping aid which shares different results based on a person’s mental health.

Valerian supplements tend to work better in menopausal and postmenopausal women whose sleep quality was greatly affected before. After taking valerian, they claimed to have better sleep quality with diminished symptoms of a sleep disorder.

      3.   Glycine

Glycine is a typical amino acid that plays a main role in the central nervous system by improving sleep patterns. The exact mechanism of action of glycine is unknown, but it is thought to play a main part in lowering the body temperature during sleep.

In a study conducted in 2006, participants who consumed around 3 grams of Glycine slept more immediately than those who took a placebo. Individuals in the glycine group also reported less fatigue the next morning with feelings of liveliness and mental clarity. You can find Glycine supplements as the counter sleeping aid in nearby stores.

      4.   Cannabidiol

CBD is a hemp-derived compound that features oils, capsules, tinctures, and balms. Since CBD contains no or less amount of THC so the psychoactive effects are absent but the CBD gets you the highest quality sleep.

In many studies, it was confirmed that CBD alleviates anxiety and acts as a natural sleeping aid. Many studies confirmed CBD could reduce the symptoms of insomnia when used alone.

      5.   Lavender

Lavender plant is found in numerous regions of the world, the plant bears purple flowers that are dried and then used for medicinal and household purposes. Lavender has a distinct and soothing fragrance that enhances sleepy feelings. Several studies confirm that just smelling lavender oil before sleep is enough to improve sleep quality, esp in individuals with insomnia complaints.

A study with older adults with dementia suggested going under aromatherapy with lavender oil. The therapy is effective at improving sleep disturbances symptoms. The total sleep time of users also increased with only a few people waking up early and being unable to get back to sleep.

      6.   Magnesium

Hundreds of minerals are there but only magnesium is involved with hundreds of processes in the body including brain and heart functions. Magnesium is a trace mineral that could make it easier for a person to sleep by inducing quietness.

Studies have suggested magnesium has relaxing effects which can be potentially beneficial for regulating melatonin production. Magnesium relaxes the muscles and induces sleep!

There are many forms of magnesium available but most people combine magnesium with other sleeping aids including glycine and melatonin. One study demonstrated the effects of the magnesium, vitamin B, and melatonin combination which were greatly effective for treating asymptomatic insomnia.

Magnesium is the key to increasing GABA levels, Gamma Aminobutyric Acid is a messenger in the brain with calming effects as its features.

      7.   Passionflower

Also known as PassifloraIncarnata is an herbal remedy for insomnia. This species of flower is associated with sleep improvements that first came from North America. Passionflower sleeping aid benefits have been tested in animal studies although more data is to be compiled for human subjects.

A study compared the effect of passionflower tea and a placebo made from parsley leaves, each participant drank each tea about an hour before bedtime for 1 week. Participants who drank passionflower tea noticed lucid dreaming and immediate sleep more than the placebo group.

Best Sleeping Pills by NooCube

Struggling to sleep is like fighting a never-ending battle and switching sides to another in bed continuously. Insomnia is a distressing condition that can take out all the liveliness in your life and it makes you cranky, tired, and less creative with impaired mental and physical performances.

There is so much commonality among insomnia patients as 35% of the adults deal with different severe conditions. There are three types of insomnia and chronic insomnia is the most severe one.

To resolve this issue, the best thing according to the experts is over-the-counter sleeping pills available on the market.

Currently, millions of people are searching for the right sleeping aids but most prefer the OTC ones.

This section is to tell whether you can buy the best sleeping pills in the stores online.

  • Best OTC Sleeping Pills GNC

At GNC, you can find CBS gummies that may not be the right solution since it comes along. Although melatonin lozenges didn’t work in most people who purchased it from GNC and tried it for almost a year. Note, to make melatonin work, you may take it in capsule form or higher dosages. GNC may be a good place for dietary supplements but it doesn’t have the best sleeping aid of 2026 – which means NooCube Sleep.

  • Sleeping Pill Walmart

Walmart has several sleeping aids and most of them contain Diphenhydramine HCL which is not OTC sleeping aid. Even if you can buy these products over the counter, you may be informed about the negative consequences of Diphenhydramine which affects the cardiovascular as well as the entire nervous system.

Nearly 90% of sleeping pills at Walmart have pharmaceutical chemicals inside and not the ones we speculated about and mentioned above. Such chemicals hold the ability to habit-forming and they can be purchased from any pharmacy nearby.

  • Over the Counter Sleeping Pills Walgreens

Just what we were talking about, even Walgreens are short of over-the-counter sleeping pills. The products related to sleep you can find there have doxylamine succinate or diphenhydramine which is again, a habit-forming chemical and is not recommended for someone battling against insomnia. Most sleeping aid products on Walgreens have FDA-approved drugs but unless the doctor hasn’t prescribed you the medication, it would be risky to rely on such compounds for sleep induction.

  • Best Sleeping Pills Over the Counter

Only a small number of melatonin supplements are found on Amazon and there is nothing you can find in there besides chemical-based sleeping pills. Organic nighttime sleeping aid are available on Amazon but there is a need for looking out for their manufacturer as most products sold on Amazon have no manufacturing details. These are the products from third-party sellers who may or may not be trustworthy.

Sleeping Pills Near Me


If you are looking for sleeping pills nearby, you should stop your quest right now because the best OTC sleeping aid can be found online.

Men and women from different countries of the world search for the same thing although the search engine presents them according to their region.

Let us see which country sleeping pills are becoming popular and what should they do to get their hands on the best one.

  • Best Sleeping Pills USA

There are countless sleeping pills in the USA most of which are found in cough syrup and antihistamine medications. Despite the FDA warnings, US people abuse sleeping pills as they get a different type of arousal from consuming them. This is why the trend of OTC sleeping aids is rising fast in the US for putting drug abuse to an end.

  • Best Over the Counter Sleeping Pills UK

You may see UK people chugging Benadryl syrup because it contains multiple antihistamines which induce sleep immediately. You can also find the best over-the-counter sleeping pills in the UK but that wouldn’t be from Barrett and Hodgson or boots pharmacy. Again, you have to go online and find the website of our best-sold and top-ranked sleeping pills over the counter.

  • Sleeping Pills Canada

By the reports, nearly 1/3rd people of in Canada take sleeping pills on regular basis. These are either sedative or hypnotics or tranquilizers which affects the brain or spinal cord. Doctors and healthcare providers only prescribe these drugs for critical sleep problems. You can find these drugs are also being used whenever you see someone struggling with anxiety or alcohol withdrawal symptoms.

  • Best Sleeping OTC Pills Australia

In Australia, the laws of TGA are very strict, especially about Schedule compounds including sleeping pills. Doxylamine is the most prescribed and strongest OTC sleeping aid in there which again is an antihistamine. It is only prescribed to sleep-deficient individuals for short-term use and whoever prescribes it will assess the patient’s history first.

Best OTC Sleeping Pills – 2026 Updates

Let’s begin our quest for the safest sleeping pills by presenting the best one in the business.

For anyone who is battling against sleeplessness and occasional insomnia, NooCube Sleep Upgrade is effective one they can get.

When we discussed the best over-the-counter sleeping aid in the world that involves Melatonin and Glycine, nearly all of these compounds can be found in the NooCube Sleep Upgrade formula which is combined under the supervision of experts.

NooCube Sleep Upgrade is a dietary supplement that contains numerous sleep and cognition-friendly ingredients such as BacopaMonnieri, GABA, Alpha GPC, Oat Straw, Cat’s claw extract, L-Theanine, etc. The best part about NooCube Sleep Upgrade is no caffeine is available to stimulate mental jitteriness.

It works faster, it is safer than most compounds found in sleeping pills and the dosage of 4 pills per day will ignite your sleep cycle and let you sleep like a baby after a long time.

Pros

  • Caffeine-free and over the counter sleeping aid with no synthetic melatonin
  • NooCube Sleep Upgrade boosts the synthesis of natural hormones that are required for you to sleep with peace
  • As a herbal supplement, the NooCube Sleep formula has no side effects that are commonly observed with prescription sleeping pills
  • NooCube Sleep Upgrade reduces anxiety and stress levels which affect symptoms of insomnia positively. Users of NooCube reviewed as they experienced a lack of anxiety and mental stress after taking the supplement on a regular basis
  • It aids concentration level and works for better focus, affecting overall lifestyle which is the best choice for insomnia patients
  • Works for adults and individuals who are 55 years or older

Cons

  • NooCube Sleep Upgrade is expensive to some because it contains a whole supply for a month
  • As a natural sleeping aid, the NooCube Sleep Upgrade supplement is hard to find in many countries
  • It can be ordered from the official website of Wolfson Berg Limited

NooCube Over the Counter Sleeping Aid Pricing

The official website of NooCube Sleep Upgrade proposed these packages which can save you 70% of your cash.

  • One-month supply package of NooCube Sleep Upgrade will cost users $64.99
  • Two-month supply package is available for $129.99
  • Five-month supply of NooCube Sleep Upgrade will cost around $194.99

Just when you’ve found out NooCube Sleep Upgrade is a natural sleeping aid and has no side effects, what is even more surprising is the money-back guarantee it provides. NooCube offers a full 60-day money-back guarantee. If the customer is not happy with his/her purchase for any reason, they can simply return it within 60 days, and the manufacturers will refund your purchase price in full.

Conclusion – Over the Counter Sleeping Pills with No Risks!

Sleep cycle interruption could unleash a variety of mental sicknesses and it impacts the overall general creativity of a person. If you are an adult and dealing with insomnia, it is better to find a way rather than making it linger even more so it could turn into a serious thing.

Insomnia is treatable and you can’t believe even a small number of ingredients can be tremendously helpful – the only thing is to consider using it on regular basis. Medicines that you can find at the drugstore or nearby markets will have a heap of compounds that are not natural and may lead to a list of side effects.

NooCube Sleep Upgrade is a effective OTC sleeping aid that can help you attain those good night sleeps faster. 

It has no caffeine so taking it at night won’t limit your creativity or passion for work. Ensuring you will get maximum bedtime and limit screen exposure before going to the bed is the key to attaining faster results from NooCube Sleep Upgrade.

CONTACT:

Company: NooCube

Email: support@noocube.com

Order Phone Support: UK: +44 191 743 4476 / US: +1 (970) 671-7706 (Monday-Friday, 9:00am-5:00pm)

Advertise with us: Info@allprsolution.com

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs




Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs

BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADCOrum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief Scientific Officer (CSO). Dr. May brings more than 20 years of oncology and immunology research experience with a track record of advancing antibody drug conjugates (ADCs), T-cell engagers, and other next-generation therapeutic platforms from concept to clinical evaluation.


“Chad has repeatedly demonstrated an ability to take bold scientific concepts and advance them into clinical candidates across multiple therapeutic modalities,” said Sung Joo (SJ) Lee, Ph.D., Founder and CEO of Orum. “His leadership experience in ADCs, T-cell engagers, and structure-driven platform design aligns with Orum’s commitment to precision engineering the next generation of degrader-antibody conjugates. Chad’s expertise strengthens our position as a leader in DAC innovation and supports our progress toward meaningful clinical milestones.”

As CSO, Dr. May will provide scientific vision and R&D leadership, guiding the strategic direction, discovery, and advancement of Orum’s pipeline, including the continued evolution of the Company’s proprietary DAC platforms and programs. He will oversee scientific strategy across discovery, translational research, and preclinical development and will play a central role in shaping the next stage of Orum’s technology innovation and pipeline growth.

“The opportunity to join Orum at this stage of growth is incredibly compelling,” said Dr. May. “The Company’s Dual-Precision Targeted Protein Degradation approach provides a powerful foundation for creating new classes of degraders guided by antibody specificity. I am excited to work closely with the talented scientific and leadership teams to advance Orum’s DAC platforms, expand therapeutic applications across cancer and other serious diseases, and drive the next wave of innovation in degrader-antibody conjugates.”

Dr. May joins Orum from Serotiny, where he served as CSO and oversaw the advancement of a novel gene and cell therapy platform through the company’s post-acquisition integration into Johnson & Johnson. Previously, he served as Senior Vice President of Research and Development at Maverick Therapeutics, where he co-founded and built the R&D organization, advanced multiple conditionally active T-cell engager programs into clinical trials, and led the company’s build-to-buy collaboration with Takeda. Earlier in his career, Dr. May held scientific leadership roles at Pfizer, where he led teams developing T-cell engagers and ADCs and advanced several programs into IND-enabling studies and clinical development. His prior work at ImClone Systems involved the design, conjugation, and evaluation of antibody-based therapeutics. Over his career, Dr. May has built and led high-performing scientific teams, contributed to numerous first-in-class program nominations, and authored more than 30 publications and patents.

About Orum’s TPD²® Approach

Orum’s unique Dual-Precision Targeted Protein Degradation (TPD²®) approach builds novel targeted protein degraders combined with the precise cell delivery mechanisms of antibodies to generate innovative, first-in-class, cell-selective TPDs for the treatment of cancer and other serious diseases. Orum has developed new targeted protein degrader payloads to specifically degrade an intracellular target protein within cancer cells via the E3 ubiquitin ligase pathway. Conjugated to antibodies, the payloads are designed to be delivered specifically to target cells and precisely degrade the intracellular target protein of interest.

About Orum Therapeutics

Orum Therapeutics is a public biotech pioneering the development of cell-specific, targeted protein degraders (TPD²®) with the precision of antibody targeting to develop the next generation of degrader antibody conjugates (DACs) for oncology and beyond. The company is advancing its GSPT1-directed TPD² programs and developing novel degrader payloads to expand the potential of targeted protein degradation. Orum’s novel targeted protein degrader payloads are designed to selectively degrade key intracellular proteins, offering a highly targeted approach to treating difficult-to-treat diseases. Orum is located in Lexington, MA, US, and Daejeon, South Korea. For more info, visit www.orumrx.com.

Orum Therapeutics Forward-Looking Statements

This press release contains forward-looking statements that are based on the current expectations and beliefs of Orum Therapeutics, Inc. (“Orum”). Statements in this release regarding matters that are not historical facts, including, but not limited to, statements relating to the development of new classes of degraders; the development of a next generation of degrader-antibody conjugates; the advancement of Orum’s pipeline, including DAC platforms and programs; the expansion of therapeutic applications; the advancement of programs to the clinical stage; and the achievement of clinical milestones are forward-looking statements. These forward-looking statements are based on management’s expectations and assumptions as of the date of this release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, the uncertainty of success in research and development activities; competition from alternative therapies; and risks related to the recruitment and retention of key employees, fluctuating markets and economic conditions, and future fundraising. The forward-looking statements in this presentation speak only as of the date of this release, and Orum undertakes no obligation to update or revise any of the statements. Orum cautions investors not to place considerable reliance on the forward-looking statements contained in this release.

Contacts

Corporate: IR/PR, Orum Therapeutics, media@orumrx.com
Media: Jessica Yingling, Ph.D., President, Little Dog Communications Inc., jessica@litldog.com

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia




Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia

SAN DIEGO, Jan. 04, 2026 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), today announced that the company will host a conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET to provide an update on PALSONIFY™ (paltusotine) commercialization and disclose topline results from the fourth cohort of the Phase 2 trial of atumelnant in congenital adrenal hyperplasia.

Conference Call and Webcast Details
Management will hold a live conference call and webcast on Monday, January 5, 2026 at 8:30 a.m. ET. A live question-and-answer session will follow the prepared remarks. To access the live audio-only webcast, click here. The archived webcast will also be accessible on the Events & Presentations page in the Investors section of the Crinetics’ website at www.crinetics.com/events. To participate, please dial 1-833-470-1428 (domestic) or 1-646-844-6383 (international) and refer to Access Code 640078.

ABOUT CRINETICS PHARMACEUTICALS
Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs. Crinetics is focused on discovering, developing, and commercializing novel therapies, with a core expertise in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology and properties.

Crinetics’ lead product, PALSONIFY™ (paltusotine), is the first once-daily, oral treatment approved by the U.S. FDA for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option. Paltusotine is also in clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics’ deep pipeline of 10+ disclosed programs includes late-stage investigational candidate atumelnant, which is currently in development for congenital adrenal hyperplasia and ACTH-dependent Cushing’s syndrome, and CRN09682, a nonpeptide drug conjugate candidate that is being developed to treat SST2 expressing neuroendocrine tumors and other SST2 expressing solid tumors. Additional discovery programs address a variety of endocrine conditions such as neuroendocrine tumors, Graves’ disease (including Graves’ hyperthyroidism and Graves’ orbitopathy, or thyroid eye disease), polycystic kidney disease, hyperparathyroidism, diabetes, obesity, and GPCR-targeted oncology indications.

Investors:
Gayathri Diwakar
Head of Investor Relations
gdiwakar@crinetics.com
(858) 345-6340

Media:
Natalie Badillo
Head of Corporate Communications
nbadillo@crinetics.com
(858) 345-6075

SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement

SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement




SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order governing the Company’s board composition and corporate actions pending trial, and announced the engagement of Zhonghua Certified Public Accountants LLP (“Zhonghua”), an affiliate of the global accounting network UHY International, as the Company’s independent auditor and registered public accounting firm.

Update on Antigua High Court Order

Further to the order issued by the Antigua High Court (the “Court”) previously disclosed by the Company in a press release dated December 17, 2025, the Court has updated its order to provide that directors Mr. Simon Anderson, Mr. Shan Fu, Mr. Shuge Jiao, Dr. Chiang Li, Mr. Yuk Lam Lo, Mr. Yumin Qiu, Mr. Yu Wang, Ms. Rui-Ping Xiao, Mr. Andrew Y. Yan and Mr. Weidong Yin (collectively, the “Board”), will comprise the Board of the Company until the trial listed in late April/early May 2026. Ms. Rui-Ping Xiao has resigned from the Board due to personal reasons. Seven of nine of the Board members are independent and 100% of the members of the Company’s Audit, Compensation and Nominating & Corporate Governance Committees are independent.

Update on Auditor Engagement

The Company further announced that the Audit Committee of the Board approved the engagement of Zhonghua as the Company’s independent auditor effective December 31, 2025. The change was not made due to any disagreements with UHY LLP. Zhonghua is a public accounting firm registered in the People’s Republic of China and is also registered with the Public Company Accounting Oversight Board (PCAOB) in the United States. Zhonghua is a member of UHY International, one of the world’s leading accounting networks; its engagement supersedes that of UHY LLP, which is part of the same global network.

This development follows the Company’s previously announced update regarding auditor engagement and will support SINOVAC’s continued focus on its financial reporting and audit workstreams. The Company remains committed to completing the requisite audit procedures and regulatory filings as expeditiously as practicable and seeks to maintain compliance with applicable U.S. SEC and Nasdaq requirements.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s or Board’s control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.

The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.

SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world’s first inactivated SARS vaccine (Phase I completed), China’s first H5N1 influenza vaccine (Panflu®), the world’s first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.

Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.

With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.

For more information, please see the Company’s website at www.sinovac.com.

Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report




Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq’s Listing Rule 5250(c)(2) since the Company did not timely file a Form 6-K containing an interim balance sheet and income statement as of the end of its second quarter of year 2025.

As previously disclosed, the Company received a delisting determination letter (the “Staff Determination”) from Nasdaq in November 2025. The Company requested a hearing before the Nasdaq Hearings Panel to appeal the Staff Determination on November 19, 2025. Nasdaq has informed the Company that the Nasdaq Hearings Panel will also consider the matter addressed in the Notification Letter at a hearing scheduled for January 8, 2026 at which the Company has been invited to present its views regarding this matter.

The Company is evaluating the Notification Letter and intends to present its plan and views to the Nasdaq Hearings Panel at the scheduled hearing with the objective of maintaining its Nasdaq listing.

Safe Harbor Statement

This announcement contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s or Board’s control, which may cause actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the U.S. Securities and Exchange Commission. The Company and Board do not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

About SINOVAC

Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of “supply vaccines to eliminate human diseases”, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.

The company’s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive®, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.

SINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world’s first inactivated SARS vaccine (Phase I completed), China’s first H5N1 influenza vaccine (Panflu®), the world’s first H1N1 influenza vaccine (Panflu.1®), and CoronaVac®, the most widely used inactivated COVID-19 vaccine globally.

Beyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.

With a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.

For more information, please see the Company’s website at www.sinovac.com.

Contacts

Investor and Media Contact

Sinovac Biotech Ltd.

Email: ir@sinovac.com

CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk

CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk




CJC 1295 Ipamorelin Unveiled 2026: Examining the Science Behind CJC-1295 Peptides and Growth Hormone Stack for Muscle Growth By CrazyBulk

Discover how CJC-1295 peptide stack research has influenced CrazyBulk’s Growth Hormone Stack, designed to support recovery speed, lean muscle, and training output.

Intro

New York City, NY, Jan. 04, 2026 (GLOBE NEWSWIRE) —  Amid continued global interest in performance science, recovery research, and hormone-related wellness innovation, growth hormone–focused formulations are receiving renewed attention across medical, fitness, and supplement research communities. Recent industry briefings and research summaries have highlighted increasing discussion around growth hormone–releasing peptides such as CJC-1295 and Ipamorelin, alongside a parallel rise in structured supplement stacks designed to support similar biological pathways through non-peptide formulations. This convergence of peptide science and advanced nutritional engineering has prompted renewed examination of how growth hormone signaling, IGF-1 activity, and recovery mechanisms are being addressed across different regulatory frameworks.

As part of this broader trend, growth hormone stacks developed using evidence-informed ingredient strategies are now being positioned as accessible, research-inspired alternatives that reflect insights drawn from peptide science without crossing into prescription-only territory. CrazyBulk’s Growth Hormone Stack has emerged within this context as a structured formulation approach that integrates multiple products designed to support growth hormone pathways, muscle protein synthesis, recovery signaling, metabolic efficiency, and training performance.

Visit the Official Website For More Details

What Is CJC-1295 Ipamorelin?

CJC-1295 Ipamorelin refers to a peptide pairing widely discussed in clinical and research settings for its role in stimulating endogenous growth hormone release. Rather than supplying synthetic growth hormone directly, these peptides are studied for their ability to interact with receptors involved in natural growth hormone secretion patterns. CJC 1295 stack is a growth hormone–releasing hormone (GHRH) analog, while Ipamorelin functions as a growth hormone secretagogue, collectively supporting pulsatile hormone release rather than continuous elevation.

In research literature, this pairing is often examined for its theoretical ability to elevate growth hormone and downstream insulin-like growth factor-1 (IGF-1) levels while maintaining physiological rhythms. These mechanisms have drawn attention within longevity research, recovery science, and metabolic studies, although peptide therapies remain subject to medical oversight and regulatory limitations.

The relevance of CJC-1295 Ipamorelin to the supplement industry lies not in direct replication, but in conceptual influence. Insights from peptide research have informed how formulators approach ingredient selection, timing strategies, and synergistic combinations aimed at supporting similar biological pathways through nutritional means. Growth hormone stacks such as those developed by CrazyBulk reflect this translation of peptide science into structured supplement systems designed for broader accessibility.

Understanding CJC-1295 Ipamorelin provides context for why growth hormone signaling has become a focal point in modern performance supplementation. Rather than replacing natural processes, the emphasis has shifted toward supporting the body’s own anabolic and recovery mechanisms through evidence-aligned formulation strategies.

Inspired by growth hormone and peptide research – Visit the Official CrazyBulk Website

Understanding Ipamorelin and Growth Hormone Signaling

Ipamorelin is primarily studied for its selective interaction with ghrelin receptors involved in growth hormone release. Unlike earlier secretagogues, Ipamorelin has been examined for its relative specificity, meaning it is less associated with stimulation of cortisol or prolactin pathways in research contexts. This selectivity has made it a point of interest in discussions around controlled growth hormone modulation.

Growth hormone signaling itself plays a multifaceted role in the body, influencing protein synthesis, tissue repair, metabolic regulation, and cellular regeneration. Rather than acting continuously, growth hormone is released in pulses, particularly during deep sleep and post-exercise recovery periods. This pulsatile nature is considered central to its physiological effectiveness.

Supplement developers have closely studied these signaling patterns when designing growth hormone–supportive formulations. Rather than aiming for artificial elevation, modern stacks emphasize nutrient timing, amino acid availability, and hormonal support pathways that align with natural secretion cycles. CrazyBulk’s Growth Hormone Stack reflects this approach by incorporating compounds associated with nitric oxide activity, protein synthesis support, testosterone optimization, and metabolic activation.

By understanding how Ipamorelin functions within growth hormone signaling research, it becomes clearer why supplement stacks focus on indirect pathway support rather than hormone replacement. The objective is alignment with biological rhythms, an approach increasingly reflected in next-generation performance formulations.

Train harder, recover faster, and stay ready for the next challenge

The Science Behind Growth Hormone Pulses and IGF-1 Activity

Growth hormone exerts many of its long-term physiological effects through stimulation of insulin-like growth factor-1 (IGF-1), primarily produced in the liver. IGF-1 plays a key role in muscle cell growth, tissue repair, and anabolic signaling, making it central to performance and recovery research. Importantly, IGF-1 activity is influenced not only by total growth hormone levels but by the timing and amplitude of growth hormone pulses.

Research suggests that pulsatile growth hormone release leads to more efficient receptor signaling and downstream anabolic effects compared to sustained elevation. This insight has influenced both peptide research and supplement formulation strategies. Rather than focusing on constant stimulation, modern approaches emphasize conditions that support natural pulses—such as sleep quality, nutrient availability, and post-training recovery environments.

CrazyBulk’s Growth Hormone Stack is structured around this principle. Each component is designed to support a specific aspect of the anabolic environment, from nitric oxide–mediated nutrient delivery to testosterone support and metabolic efficiency. By addressing multiple inputs that influence growth hormone and IGF-1 activity, the stack reflects a systems-based approach inspired by endocrine research.

This emphasis on biological timing and signaling efficiency represents a shift away from simplistic single-ingredient products toward integrated performance systems grounded in hormone science.

CJC-1295-inspired muscle growth with faster recovery cycles – Visit the Official CrazyBulk Website

How CJC-1295 Peptides Work in the Body

CJC-1295 peptides are studied for their ability to bind to GHRH receptors in the pituitary gland, thereby promoting endogenous growth hormone release. Variants with extended half-life have been explored for their capacity to sustain elevated growth hormone signaling over longer periods while preserving pulsatility. This mechanism has been central to discussions around growth hormone optimization in clinical research.

Rather than acting directly on muscle tissue, CJC 1295 stack influences upstream hormonal signaling that affects protein synthesis, fat metabolism, and recovery processes. These systemic effects explain why growth hormone research extends beyond bodybuilding into aging, metabolic health, and regenerative studies.

Supplement developers draw from these insights by focusing on ingredients that influence similar upstream mechanisms—supporting hormonal balance, nutrient signaling, and recovery capacity. CrazyBulk’s Growth Hormone Stack applies this logic by combining compounds that address anabolic signaling from multiple angles rather than relying on a single pathway.

This translation of peptide research into supplement design underscores the evolving sophistication of performance nutrition, where hormonal science informs formulation architecture without replicating pharmaceutical interventions.

Optimize recovery and muscle growth the CJC-1295 way – Visit the Official CrazyBulk Website

Why CJC-1295 and Ipamorelin Are Commonly Paired

In research contexts, CJC-1295 and Ipamorelin are often discussed together due to their complementary mechanisms. While CJC-1295 stimulates growth hormone release via GHRH pathways, Ipamorelin activates ghrelin receptors, resulting in synergistic stimulation of growth hormone pulses. This pairing has become a reference point in discussions about optimized hormone signaling.

The concept of synergy has been widely adopted in supplement formulation. Rather than isolating single ingredients, growth hormone stacks integrate multiple compounds that work through different but complementary pathways. CrazyBulk’s Growth Hormone Stack mirrors this principle by combining products that support nitric oxide production, anabolic signaling, testosterone levels, and metabolic activation.

This systems-based approach reflects lessons drawn from peptide pairing research: effective performance support often requires coordinated input across multiple physiological systems.

Research Insights on Body Composition, Recovery, and Performance

Growth hormone and IGF-1 signaling are consistently linked in research to lean mass maintenance, tissue repair, and recovery efficiency. Studies examining growth hormone modulation frequently explore outcomes related to muscle protein synthesis, fat metabolism, and exercise recovery timelines.

While peptide therapies operate under medical supervision, supplement stacks apply these insights through nutritional strategies. CrazyBulk’s Growth Hormone Stack is structured to support training adaptation by enhancing nutrient delivery, supporting anabolic hormones, and promoting efficient recovery environments.

By integrating multiple performance-focused compounds, the stack reflects a holistic interpretation of growth hormone research rather than a narrow focus on muscle size alone.

CJC-1295 principles, translated into a complete growth system – Visit the Official CrazyBulk Website

Growth Hormone Stacks: How Peptide Research Has Influenced Supplement Formulas

Advances in peptide research have significantly shaped how modern supplement formulas approach growth hormone support. Rather than attempting to replicate pharmaceutical or peptide-based interventions, contemporary growth hormone stacks are designed to reflect the underlying biological principles observed in research settings—namely hormonal signaling efficiency, nutrient timing, and synergistic pathway activation. This evolution has led to multi-component systems that address growth hormone–related processes indirectly through nutrition and performance science.

CrazyBulk’s Growth Hormone Stack exemplifies this research-informed approach. Drawing conceptual inspiration from peptide studies involving compounds such as CJC-1295 Ipamorelin, the stack focuses on creating an internal environment conducive to anabolic signaling, recovery processes, and metabolic efficiency. Instead of single-ingredient supplementation, the formulation strategy integrates multiple products, each aligned with a distinct physiological role.

Peptide research emphasizes pulsatile hormone release, downstream IGF-1 activity, and coordinated endocrine signaling. These insights have influenced how CrazyBulk structures its stack—combining nitric oxide support, amino acid delivery, testosterone optimization, connective tissue support, and metabolic activation into a unified system. The result is a supplement architecture designed to function cohesively rather than in isolation.

This approach reflects a broader shift in the supplement industry toward systems-based formulation, where performance outcomes are supported through multiple complementary mechanisms. By aligning supplement design with established research concepts from peptide science, CrazyBulk’s Growth Hormone Stack positions itself within a new generation of performance nutrition that prioritizes biological alignment, formulation synergy, and structured functionality.

Visit the Official Website For More Details on CJC 1295 Stack

Benefits of CJC-1295 Peptide Supplements for Men

In research and clinical discussions, CJC-1295 peptide supplementation is often examined in the context of male physiology due to its association with growth hormone signaling, metabolic regulation, and recovery processes. Growth hormone plays a central role in maintaining lean tissue, supporting protein synthesis, and facilitating tissue repair—functions that are particularly relevant to male performance, aging, and training adaptation.

Studies exploring growth hormone–releasing peptides frequently reference outcomes related to body composition balance, connective tissue health, and exercise recovery efficiency. While peptide therapies are typically administered under medical supervision, the underlying biological benefits discussed in research literature have informed how supplement developers approach male-focused performance formulations.

For men, growth hormone–related pathways are closely linked to muscle maintenance, fat metabolism, and overall physical resilience. Research insights suggest that supporting these pathways may contribute to improved training recovery cycles, enhanced nutrient utilization, and sustained anabolic signaling. These concepts have become foundational in the development of growth hormone–inspired supplement stacks.

CrazyBulk’s formulation philosophy reflects these principles by targeting multiple inputs that influence male performance systems. Rather than addressing a single outcome, the focus is on supporting the broader hormonal and metabolic environment associated with growth hormone activity. This research-aligned approach underscores why growth hormone science continues to influence product development aimed at male wellness and performance contexts.

Build muscle using the same science behind CJC-1295 – Visit the Official CrazyBulk Website

How CrazyBulk Growth Hormone Stacks Benefit Muscle Growth & Strength

CrazyBulk’s Growth Hormone Stack is structured as a multi-product system designed to support muscle development and strength output through complementary mechanisms. Each component plays a defined role within the overall formulation strategy, contributing to an integrated performance framework rather than isolated effects.

HGH-X2 is formulated to support nitric oxide pathways and amino acid signaling, which are associated with nutrient delivery and anabolic processes. Deca-Max focuses on connective tissue support and recovery pathways, aligning with research emphasizing joint integrity and tissue resilience in strength training contexts. D-Bal is designed around protein synthesis support, addressing one of the core drivers of muscle development. Testo-Max targets testosterone-related pathways, which play a synergistic role alongside growth hormone in muscle strength and performance. Clenbutrol contributes to metabolic activation and energy utilization, supporting lean mass maintenance during intense training phases.

Together, these products form a coordinated system that supports muscle growth and strength through multiple biological inputs. Rather than relying on a single mechanism, the stack emphasizes formulation synergy, reflecting principles derived from endocrine and performance research. This integrated design allows the Growth Hormone Stack to address training adaptation, recovery capacity, and muscular output in a structured and research-informed manner.

Push past plateaus with CJC-1295-based formulation logic

CrazyBulk Growth Hormone Stack: Linking CJC-1295 Science to Muscle Growth, Recovery, and Fat Reduction

Ongoing research into growth hormone–releasing peptides such as CJC-1295 has placed renewed emphasis on the role of recovery efficiency, metabolic balance, and anabolic signaling in long-term muscle development. One of the most widely discussed benefits associated with CJC-1295 research is its relationship to improved recovery cycles, reduced training downtime, and support for lean muscle preservation during intense physical stress. These same principles now inform the design of advanced growth hormone–inspired supplement systems.
CrazyBulk’s Growth Hormone Stack has been structured around these core concepts. Rather than acting as a direct hormone intervention, the stack focuses on supporting the physiological conditions commonly associated with growth hormone activity—enhanced nutrient delivery, improved protein synthesis efficiency, optimized hormonal balance, and metabolic activation. Together, these factors contribute to faster recovery between sessions, allowing the body to remain primed for repeated training challenges.
Recovery speed plays a critical role in muscle growth. When downtime is reduced, training frequency and output can be maintained more consistently, supporting progressive overload and strength adaptation. The CrazyBulk Growth Hormone Stack addresses this by combining compounds that support connective tissue integrity, cellular repair processes, and anabolic signaling pathways. This aligns closely with the recovery-focused benefits frequently discussed in CJC-1295 peptide research.
In parallel, growth hormone–related pathways are also linked to fat metabolism and body composition regulation. By supporting metabolic efficiency and energy utilization, the stack contributes to an environment where lean muscle development is prioritized while excess fat storage is minimized. This dual focus on muscle growth and fat reduction reflects the holistic outcomes often associated with optimized growth hormone signaling.
As training demands increase, the body’s ability to recover, rebuild, and adapt becomes the limiting factor for muscle gains. CrazyBulk’s Growth Hormone Stack positions itself as a research-inspired performance system designed to support these processes—helping the body stay prepared for the next physical challenge while maintaining momentum toward substantial muscle development.

Where to Buy CrazyBulk’s Growth Hormone Stacks Safely

CrazyBulk’s Growth Hormone Stack is made available through official website designed to maintain product integrity, formulation accuracy, and quality assurance. Purchasing directly through authorized sources ensures that consumers receive products that align with published specifications, ingredient standards, and manufacturing controls.

Official availability also provides access to up-to-date formulation details, usage information, and batch-controlled production processes. This centralized distribution approach reflects industry best practices for supplement safety, transparency, and consistency. By maintaining controlled supply channels, CrazyBulk supports accountability across sourcing, production, and delivery stages.

Accessing the Growth Hormone Stack through verified platforms helps ensure alignment with regulatory requirements and brand-established quality benchmarks. This structured distribution model reinforces the company’s focus on reliability and product standardization within the performance supplement market.

Who May Consider CJC-1295 Stack in a Medical or Wellness Setting

CJC-1295 Ipamorelin is generally discussed within medical or wellness frameworks that involve professional oversight. Research and clinical use cases often focus on growth hormone signaling support in contexts such as age-related hormonal changes, recovery limitations, or metabolic considerations. Due to its classification and mechanism, peptide therapy is typically explored under the guidance of licensed healthcare practitioners.

Individuals considering peptide-based approaches are advised to undergo proper evaluation to determine suitability, dosing frameworks, and monitoring protocols. This ensures that growth hormone modulation is addressed within appropriate clinical parameters. The distinction between peptide therapies and supplement-based alternatives remains an important consideration in wellness planning.

While supplement stacks draw conceptual inspiration from peptide research, peptide therapies themselves remain part of regulated medical discussions. Understanding this separation helps clarify the role of CJC-1295 Ipamorelin within professional healthcare settings versus nutritional performance strategies.

Final Thoughts: CJC-1295 Peptides Have a New Name—CrazyBulk

As growth hormone research continues to influence wellness and performance innovation, its principles are increasingly reflected in advanced supplement systems. CrazyBulk’s Growth Hormone Stack represents a research-inspired interpretation of growth hormone science, translating complex endocrine concepts into a structured nutritional framework.

Rather than replicating peptide therapies, the stack applies lessons from hormonal research—synergy, timing, and pathway support—through legally accessible formulations. This approach highlights how peptide science has shaped modern supplement architecture, positioning CrazyBulk as a brand aligned with next-generation performance formulation strategies.

By integrating multiple performance-supporting components into a cohesive system, CrazyBulk’s Growth Hormone Stack reflects the ongoing convergence of research insight and nutritional innovation within the evolving performance science landscape.

For more information on CJC 1295 Stack, educational content, and direct purchasing, visit the official CrazyBulk  website
Project name: Crazybulk
244 Madison Avenue,
New York City, NY 10016-2817
Postal code: NY 10016-2817
Media Contact:
email: support@crazybulk.com
+1 888-708-6394
Company website: https://www.crazybulk.com/

Disclaimers

Publisher Responsibility Disclaimer: The publisher of this article has made every effort to ensure accuracy at the time of publication. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with the official source before making a purchase decision.

FDA Disclaimer: CrazyBulk is a dietary supplement and has not been evaluated by the U.S. Food and Drug Administration (FDA). It is not intended to diagnose, treat, cure, or prevent any disease.

Health Disclaimer: The information provided in this article is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional before beginning any new supplement, especially if you have a medical condition or are taking prescription medication.

Results Disclaimer: Individual results may vary. Some users report noticeable benefits, while others experience little to no change. Factors such as diet, lifestyle, and overall health can influence outcomes.

Pricing Disclaimer: Product prices, bundles, and promotions for CrazyBulk are subject to change at any time without notice. Always check the official website for the most current details.

Attachment

CONTACT: Project name: Crazybulk
244 Madison Avenue,
New York City, NY 10016-2817
Postal code: NY 10016-2817
Media Contact:
email: support@crazybulk.com
+1 888-708-6394
Company website: https://www.crazybulk.com/

Nia Therapeutics Publishes Peer-Reviewed Validation of a 60-Channel Brain Implant for Closed-Loop Neurostimulation

Nia Therapeutics Publishes Peer-Reviewed Validation of a 60-Channel Brain Implant for Closed-Loop Neurostimulation




Nia Therapeutics Publishes Peer-Reviewed Validation of a 60-Channel Brain Implant for Closed-Loop Neurostimulation

Wireless Smart Neurostimulation System records from 10× more brain sites than current adaptive implants; a large-animal study demonstrates chronic sensing, neural-state decoding, and programmable stimulation




ALLSTON, Mass.–(BUSINESS WIRE)–Nia Therapeutics announced publication in Brain Stimulation of the first in vivo validation of its Smart Neurostimulation System (SNS), a wireless, implantable brain-computer interface designed for closed-loop treatment of memory disorders.

The SNS records neural activity from 60 channels across four brain regions—an order-of-magnitude increase over commercially available devices. The NeuroPace RNS system, FDA-cleared for epilepsy, records from up to six channels; Medtronic’s Percept adaptive DBS system records from up to four.

This expanded sensing capacity reflects the distributed nature of memory, which arises from coordinated dynamics across widespread neural networks rather than from a single focal site.

“Most brain implants were developed for conditions in which a localized abnormal signal drives symptoms,” said Michael J. Kahana, PhD, co-founder and CEO of Nia Therapeutics and a professor at the University of Pennsylvania. “Decades of research show that memory depends on coordinated activity across distributed networks. The SNS was engineered to detect these patterns and respond with personalized stimulation.”

Preclinical Validation in Freely Moving Large Animals

In a chronic study of three sheep, the SNS demonstrated stable performance across core functions:

  • Neural-state decoding. Machine-learning classifiers distinguished movement from stillness with high accuracy (AUC 0.92–0.98), with performance stable throughout implantation.
  • Programmable neuromodulation. Systematic variation of stimulation parameters produced dose-dependent changes in alpha-band (8–12 Hz) and gamma-band (78–82 Hz) neural activity, confirming that stimulation reliably modulates physiological signals.
  • Biocompatibility. Histological analyses showed no adverse tissue response, with findings comparable to a commercially available control lead.

These results demonstrate that the SNS can chronically record distributed neural activity, decode behaviorally relevant brain states, and deliver stimulation with predictable effects—key prerequisites for future closed-loop neurostimulation therapies.

Building on a Decade of Human Memory Research

The SNS builds on federally funded research supported by DARPA and NIH. In prior human studies using externalized research systems, Kahana and colleagues recorded intracranial brain activity from hundreds of epilepsy patients performing memory tasks and showed that machine-learning models could predict, moment by moment, whether newly learned information would be remembered.

In sham-controlled clinical experiments, brief bursts of electrical stimulation delivered during classifier-identified poor-encoding states improved delayed recall by approximately 20%; stimulation delivered at random times produced no benefit. Those studies established the therapeutic principle underlying Nia’s approach but relied on devices unsuitable for chronic use.

This publication shows that the core capabilities required for memory-guided stimulation—high-density sensing, real-time decoding, and programmable neuromodulation—can be delivered in a fully implantable, wireless system,” said Daniel S. Rizzuto, PhD, co-founder and President of Nia Therapeutics.

Addressing an Unmet Clinical Need

Memory impairment is among the most common and disabling consequences of traumatic brain injury and age-related cognitive decline. Although recent disease-modifying drugs for early Alzheimer’s can slow progression, they do not restore lost function. Nia’s approach aims to complement such treatments by directly improving memory through targeted neuromodulation.

Nia Therapeutics is preparing for first-in-human studies, with regulatory submissions planned for 2026. The initial study will focus on patients with memory loss resulting from moderate-to-severe traumatic brain injury.

About Nia Therapeutics

Nia Therapeutics develops implantable brain-computer interfaces for memory disorders. Founded in 2018, the company’s SNS device supports closed-loop neuromodulation by detecting brain states linked to impaired memory encoding and delivering targeted stimulation. Visit www.niatx.com.

Publication Reference

Rizzuto DS, Herrema HG, Hu Z, Utin D, Kahn J, Ho C, Smiles A, Gross RE, Lega BC, Das SR, Kahana MJ. A wireless, 60-channel, AI-enabled neurostimulation platform. Brain Stimulation (2025). DOI: https://doi.org/10.1016/j.brs.2025.103013

Contacts

Media Contact
Michael Kahana, PhD, CEO, Nia Therapeutics, mike@niatx.com

Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges

Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges




Best Chocolate Weight Loss Supplement: Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges

Consumer analysis evaluates Earth Echo Cacao Bliss ingredient disclosures, ceremonial-grade processing claims, and published GLP-1 research frequently referenced in chocolate-based weight management supplement discussions as January wellness searches surge; this report does not provide medical advice or guarantee individual outcomes.

BOULDER, CO, Jan. 02, 2026 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only. It is not medical advice. Always consult a qualified healthcare professional before starting supplements. If you purchase through links in this article, a commission may be earned at no additional cost to you.

As early January begins, search interest often rises across weight-management topics, reflecting seasonal consumer attention and renewed focus on wellness goals. This consumer analysis examines how chocolate-based supplement positioning intersects three simultaneous market factors: published research documenting cacao’s influence on satiety mechanisms, predictable New Year wellness commitment patterns, and growing consumer awareness of GLP-1 hormone pathways following mainstream pharmaceutical coverage.

This analysis specifically summarizes how Earth Echo Foods positions its Cacao Bliss ceremonial-grade formulation within this context, providing consumers with a summary of publicly available ingredient disclosures, processing method claims, and research context frequently referenced in chocolate-based metabolic support supplement discussions.

Best Chocolate Weight Loss Supplement Consumer Analysis Examines Cacao GLP-1 Research as January Wellness Interest Surges

What This Analysis Provides:

This report systematically summarizes Earth Echo Foods’ publicly available ingredient disclosures, examines the research context often cited in chocolate weight loss supplement discussions, provides a safety framework based on published ingredient information, and outlines common questions consumers consider when evaluating supplement fit. This is a summary of publicly available information—not product endorsement or independent verification of efficacy claims.

Readers who want to review the company’s current product description and posted terms can view Earth Echo Foods’ official Cacao Bliss product page.

What “Best Chocolate Weight Loss Supplement” Actually Means in 2026 (And What It Doesn’t)

When consumers search for “best chocolate weight loss supplement” following advertisement exposure or social media content, they’re typically asking three distinct questions: Is there legitimate research supporting chocolate for weight management? How do I differentiate quality formulations from inferior products? Which specific product aligns with my individual needs and circumstances?

Understanding what “best” actually means requires establishing evaluation criteria rather than declaring winners. This analysis does not determine which product is objectively “best” as individual needs, preferences, metabolic responses, and health circumstances vary dramatically across consumers. Instead, this section establishes the framework readers can use to conduct their own evaluations.

Category Definition: What Makes a Chocolate Supplement Different From Conventional Chocolate

The fundamental distinction consumers must understand: chocolate-based weight management supplements represent a specific product category that differs substantially from conventional chocolate products purchased in grocery stores. The differentiation centers on processing methods, ingredient purity, bioactive compound preservation, and formulation strategy.

According to research published in The Journal of Agricultural and Food Chemistry, conventional chocolate processing—including high-temperature roasting (often 300-450°F) and alkaline treatment called Dutching—reduces antioxidant content substantially compared to minimally processed cacao. This processing degradation explains why eating conventional milk chocolate doesn’t produce the metabolic outcomes observed in research studies using minimally processed cacao.

The term “ceremonial-grade cacao” references traditional preparation methods used in Central and South American cultures, where cacao beans undergo sun-drying and minimal processing to preserve naturally occurring compounds. Modern supplement formulations using ceremonial-grade positioning claim to maintain these bioactive compounds through temperature-controlled processing rather than high-heat industrial methods.

Evaluation Criteria for Comparing Chocolate-Based Supplements

Consumers evaluating options in this category should verify the following information from company sources:

Processing Method Transparency: Does the company disclose whether cacao is roasted at high temperatures or processed using low-heat methods? Is alkaline treatment (Dutching) used? Temperature and pH manipulation directly impact compound preservation.

Ingredient Disclosure Standards: Does the company list specific ingredient amounts or hide formulation details behind “proprietary blend” language? Proprietary blends prevent consumers from comparing dosages or evaluating adequacy against research contexts.

Third-Party Testing Verification: Does the company provide documentation of third-party testing for purity, potency, and contaminant screening? Quality manufacturers invest in independent verification.

Company Legitimacy Indicators: Can consumers easily find contact information including phone numbers, email addresses, and physical headquarters locations? Are return policies clearly stated with adequate evaluation windows? Legitimate companies provide transparent communication channels.

Research Context Alignment: When companies reference research studies, can consumers verify those studies exist through independent searches? Are study details accurately represented or selectively presented?

These criteria provide a methodology for evaluation across any product in this category, not just Earth Echo Foods’ Cacao Bliss specifically.

Why January 2026 Search Volume Patterns Create Heightened Consumer Interest

Understanding seasonal search behavior provides context for current market attention on chocolate-based weight management supplements and the timing of this analysis. According to recurring patterns observable in public trend tools, weight loss-related search terms often show elevated interest during the first weeks of January compared to late-year baseline periods.

This surge reflects several psychological and cultural factors: New Year resolution commitment psychology creates temporary motivation enhancement as individuals set fresh goals following the symbolic January 1st temporal landmark. Post-holiday awareness develops after approximately two months of seasonal indulgence (Thanksgiving through New Year’s), creating desire for course correction. Increased health consciousness emerges as individuals reflect on aging, mortality, and wellness priorities during year-end periods.

The GLP-1 Cultural Moment

A significant factor influencing current chocolate weight loss supplement interest involves widespread consumer awareness of GLP-1 hormone function, driven by prescription GLP-1 medication coverage in mainstream media. Pharmaceutical interventions that work by mimicking GLP-1’s appetite suppression effects have received extensive discussion, educating consumers about this satiety hormone pathway.

This pharmaceutical awareness creates consumer curiosity about whether dietary approaches can support natural GLP-1 production at meaningful levels—a question that published research has begun examining. The appeal of “chocolate instead of injections” messaging capitalizes on this cultural moment where consumers understand GLP-1’s function but seek alternatives to prescription interventions.

Consumer Sophistication About Processing Quality

Another relevant trend involves increasing consumer attention to ingredient sourcing and processing method differentiation. Modern consumers demonstrate growing skepticism toward generic supplement positioning and increasingly seek verification of quality claims through processing transparency, sourcing documentation, and third-party testing confirmation.

This sophistication benefits companies investing in premium processing methods and transparent disclosure, as educated consumers can differentiate between conventional cocoa powder marketed as premium versus genuinely preserved ceremonial-grade formulations.

Earth Echo Cacao Bliss: What the Company Discloses About Formulation and Positioning

According to publicly available materials from Earth Echo Foods, Cacao Bliss represents a specific formulation strategy: ceremonial-grade cacao combined with seven additional ingredients positioned for synergistic metabolic support, marketed as a chocolate drink mix that may naturally support satiety hormone function when consumed as part of comprehensive wellness programs.

Founder Background and Company Positioning

Earth Echo Foods was founded by Danette May, whose publicly stated credentials include celebrity fitness trainer with 20+ years professional experience, published author of two books on health and wellness, founder of the Rise Movement wellness community, and social media presence across platforms. According to company materials, May has been featured on Access Hollywood, CBS, and Hallmark programming.

The company’s founding narrative, as presented in marketing materials, describes May’s exposure to traditional ceremonial cacao preparation during travels to Costa Rica’s blue zone region—geographic areas recognized by longevity research for unusually high centenarian populations and extended health spans. This experience reportedly inspired formulation development combining ceremonial-grade cacao with researched metabolic support compounds.

Marketing Context and Viral Attention

According to Earth Echo Foods’ marketing materials, social media content demonstrating ceremonial-grade cacao preparation and explaining GLP-1 research context generated significant consumer interest and heightened search volume for chocolate-based weight management information. The positioning capitalizes on consumer desire for natural approaches to appetite management that don’t feel restrictive or punishment-based.

Product Composition Framework

According to Earth Echo Foods’ ingredient disclosure, Cacao Bliss combines eight components:

Primary Ingredient—Ceremonial-Grade Cacao: The company states the formulation uses sun-dried cacao rather than high-heat roasted processing. According to product materials, this processing method is positioned as preserving the cacao’s naturally high antioxidant capacity. The company references ORAC (Oxygen Radical Absorbance Capacity) measurement standards in comparing antioxidant content, though specific numbers should be verified on current product labels.

Supporting Ingredient Framework:

According to company ingredient disclosures:

Organic Cinnamon: Included for blood sugar stabilization properties documented in published research. Studies from institutions including Cairo University have examined cinnamon’s influence on glucose metabolism in controlled settings.

Organic Turmeric: Positioned for anti-inflammatory properties. Research from institutions including the State University of New York School of Medicine has explored curcumin compounds’ potential influence on adipose tissue inflammation markers.

Organic Piperine (Black Pepper Extract): Included specifically to address turmeric’s well-documented bioavailability limitation. Published research demonstrates piperine increases curcumin absorption substantially, addressing a known challenge with turmeric supplementation.

Organic MCT Oil (Medium-Chain Triglycerides): Positioned for satiety hormone support. Research from institutions including Columbia University has examined MCT oil’s influence on leptin and fullness signaling.

Organic Monk Fruit Powder: Zero-calorie natural sweetener that does not trigger blood sugar elevation according to metabolic research, allowing chocolate flavor satisfaction without processed sugar content.

Organic Lucuma: Peruvian fruit providing caramel-like flavor while supporting digestive function according to traditional use documentation.

Himalayan Sea Salt: Mineral content component containing multiple trace elements according to mineral composition analysis.

Nutritional Profile: According to the company’s published nutrition label, each serving contains 35 calories with zero processed sugar content.

Important Product Category Context: Cacao Bliss is classified as a dietary supplement, not a medication. This classification carries specific regulatory implications. Dietary supplements are not reviewed or approved by the FDA as finished products before market availability. The FDA requires that supplements contain what labels claim and are free from contaminants, but does not evaluate whether marketing claims are substantiated or whether products are effective for stated purposes.

The legally required disclaimer: “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Ingredient Disclosure Review: What Research Says About Ceremonial Cacao and Metabolic Support Compounds

Understanding the research context surrounding chocolate-based supplements requires examining what published studies actually tested versus what they didn’t test. This distinction helps consumers evaluate marketing claims against evidence standards.

The Ceremonial-Grade Processing Distinction

The fundamental premise underlying ceremonial-grade cacao positioning centers on bioactive compound preservation through processing method selection. This concept has research foundation examining how temperature, pH manipulation, and processing duration affect cacao’s naturally occurring compounds.

Research published in The Journal of Agricultural and Food Chemistry documented that conventional chocolate manufacturing reduces antioxidant content substantially compared to minimally processed cacao. The study examined the progressive compound degradation that occurs through each processing stage: high-temperature roasting destroys heat-sensitive flavanols, alkaline treatment (Dutching) with potassium carbonate reduces polyphenol content, extended conching at elevated temperatures further degrades bioactive compounds.

According to research examining this progressive degradation, conventional chocolate manufacturing reduces antioxidant content substantially compared to minimally processed cacao. The study examined how each processing stage progressively affects bioactive compound profiles.

This processing research provides context for why ceremonial-grade positioning emphasizes sun-drying and low-heat methods—the goal involves preserving compounds that conventional manufacturing reduces. However, consumers should note: research examines processing methods and compound preservation generally, not specific commercial products’ efficacy.

Blood Sugar Stabilization: The Cinnamon Research Context

Multiple published studies have examined cinnamon’s influence on glucose metabolism. Research from Cairo University involving 60 participants demonstrated that daily cinnamon supplementation for one month correlated with fasting blood sugar changes in the study population. Participants’ average fasting glucose levels decreased from approximately 254 mg/dL to 126 mg/dL over the study period.

Important context: This research examines cinnamon supplementation in controlled settings with specific populations and dosages. The study does not evaluate commercial products containing cinnamon as one ingredient among several, and individual responses vary based on baseline insulin sensitivity, overall dietary patterns, medication use, and numerous other metabolic factors.

Blood sugar stability relates to weight management through multiple pathways: stable glucose levels reduce reactive hunger and carbohydrate cravings, improved insulin sensitivity affects fat storage patterns, reduced blood sugar variability decreases stress hormone release that promotes abdominal fat accumulation.

Anti-Inflammatory Compounds: The Turmeric and Piperine Combination

Research from the State University of New York School of Medicine and other institutions has explored curcumin’s potential influence on inflammatory pathways in adipose tissue. Some studies following individuals who had experienced weight loss plateaus reported changes in body composition over study periods with twice-daily turmeric supplementation, though these studies examined isolated turmeric compounds rather than comprehensive formulations.

The inclusion of piperine (black pepper extract) addresses a well-documented scientific challenge: curcumin has poor bioavailability when consumed alone. Published research demonstrates piperine increases curcumin absorption by up to 2,000%, which explains why quality formulations include this combination rather than turmeric in isolation.

Satiety Hormone Support: The MCT Oil Research

Research from institutions including Columbia University has examined medium-chain triglycerides’ influence on satiety hormone signaling, particularly leptin—the hormone that signals fullness to the brain. Studies from King’s College London found that MCT oil consumption correlated with reduced overall caloric intake in controlled research settings.

The proposed mechanism involves MCT oil’s unique metabolic pathway: unlike long-chain fatty acids that require extensive digestion, medium-chain triglycerides absorb rapidly and may influence hormone signaling more directly. However, research contexts differ from real-world supplement use in dosage, timing, overall dietary composition, and individual metabolic variability.

Critical Research-to-Product Translation Context

Every research citation above shares a common limitation: studies examine isolated ingredients under controlled conditions with specific dosages, selected participant populations, and defined protocols. Commercial product use involves multiple ingredients consumed simultaneously with potential interactions, uncontrolled real-world conditions with variable diet quality and activity levels, diverse individual metabolic responses based on age and hormones and medications and genetics, inconsistent usage patterns as daily compliance varies widely, and indefinite timeframes while research studies last weeks to months.

This gap doesn’t invalidate research relevance—it explains why individual results differ from study averages and why some consumers report substantial benefits while others experience minimal effects despite identical product use.

The GLP-1 Research Context: What Studies Actually Tested vs. What They Didn’t

The GLP-1 research represents perhaps the most frequently cited evidence in chocolate weight loss supplement marketing, and it warrants detailed examination to help consumers understand what was actually demonstrated versus what remains unproven.

Understanding GLP-1 Hormone Function

GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces when you eat. It performs several metabolic functions: signals satiety (fullness) to the brain, slows gastric emptying so food stays in your stomach longer, reduces appetite and food-seeking behavior, improves insulin sensitivity, and supports healthy blood sugar regulation.

Prescription GLP-1 medications work by mimicking this hormone at therapeutic doses, creating pronounced appetite suppression effects that facilitate significant weight loss in clinical trials. These medications represent a different mechanism and magnitude than dietary approaches to supporting natural GLP-1 production.

The 2020 Nutrition Journal Study: What Was Actually Tested

The frequently referenced research appeared in the journal Nutrition in 2020. The study methodology involved 48 participants separated into two groups—one consuming water, another consuming a cacao-based beverage. Following a standardized glucose tolerance test (where participants consumed 50 grams of glucose), researchers measured GLP-1 hormone levels at intervals.

Results: Two hours post-consumption, the cacao group demonstrated nearly double the GLP-1 levels compared to the water control group. This relative change was observed under short-term laboratory conditions and does not establish clinical significance, durability, or applicability to commercial supplement use.

Significance: The study demonstrates that dietary compounds may naturally influence the same satiety hormone targeted by prescription GLP-1 medications, though the mechanisms and magnitude differ substantially from pharmaceutical interventions.

What This Study Did NOT Test

Critical limitations consumers must understand:

It Did Not Test Commercial Products: The research examined a cacao-based beverage prepared for research purposes with controlled cacao content, not finished commercial supplements like Cacao Bliss or any other branded product. Study findings cannot be directly attributed to specific products without separate testing.

It Did Not Measure Weight Loss Outcomes: The study measured hormone response over hours, not weight changes over weeks or months. GLP-1 influence is theoretically relevant to weight management, but this study didn’t track whether participants lost weight.

It Did Not Establish Effective Dosing: The study used specific cacao amounts under controlled conditions. The optimal dosage, timing, frequency, and duration for weight management outcomes remain unclear.

It Did Not Evaluate Long-Term Responses: Hormone measurements occurred during a single session. Whether daily cacao consumption maintains similar GLP-1 effects over months, whether the body adapts and diminishes response, or whether effects accumulate favorably all remain unknown.

It Did Not Compare to Pharmaceutical Magnitude: While GLP-1 levels nearly doubled, the absolute magnitude remains substantially lower than prescription GLP-1 medication effects. The clinical significance of dietary GLP-1 enhancement versus synthetic hormone delivery differs considerably.

The UC San Diego Weight Loss Research Context

Two additional studies from the University of California San Diego School of Medicine examined weight loss outcomes with cacao consumption, providing different context than the GLP-1 hormone study:

Study 1: Twenty-four overweight participants consumed cacao cookies twice daily (before breakfast and dinner) alongside light exercise protocols. After eight weeks, researchers reported average weight reduction of approximately 7 pounds and waist circumference decrease of 1.5 inches in the study population.

Study 2: Fifteen participants followed similar protocols over four weeks, with researchers reporting average weight loss of 5.3 pounds and waist reduction of 1.4 inches. Participants also reported quality-of-life improvements including better mobility, improved cholesterol markers, and lower anxiety/depression scores.

Critical Context for Both Studies:

These studies examined minimally processed cacao consumption as part of comprehensive protocols including exercise components, not cacao supplementation in isolation. Participants followed structured approaches with regular monitoring—conditions that differ substantially from independent supplement use without professional guidance or accountability structures.

The studies demonstrate that cacao consumption within comprehensive wellness programs correlated with weight loss in research populations, but they cannot establish whether cacao specifically caused the outcomes, whether exercise was the primary driver, whether accountability and monitoring influenced results more than ingredients, or whether similar outcomes would occur with unstructured supplement use.

The Honest Assessment for Consumers

Based on available research, what can consumers reasonably conclude?

Published evidence supports that cacao consumption influences GLP-1 hormone response and that minimally processed cacao consumption within structured wellness programs correlates with weight loss outcomes in research populations. The bioactive compounds in cacao (flavanols, theobromine, others) have documented effects on metabolic pathways, blood sugar regulation, and satiety signaling.

However, research does not demonstrate that drinking a commercial chocolate supplement guarantees weight loss, that affects equal pharmaceutical interventions in magnitude, that results occur without comprehensive lifestyle approaches, or that all individuals respond similarly regardless of metabolic differences.

The gap between “research shows cacao has metabolic effects” and “this supplement will help you lose weight” represents the uncertainty every consumer must acknowledge when evaluating products in this category.

Ceremonial-Grade vs. Conventional Processing: What the Distinction Means for Bioactive Compound Preservation

Understanding processing method differentiation helps consumers evaluate whether premium pricing for ceremonial-grade products represents genuine quality differences or merely marketing positioning.

The Conventional Chocolate Manufacturing Sequence

According to chocolate industry documentation, commercial chocolate production typically involves nine processing stages: high-temperature roasting (often 300-450°F, destroying heat-sensitive compounds), shell removal and nib extraction, grinding into chocolate liquor, alkaline treatment or Dutching (pH manipulation with potassium carbonate to reduce bitterness), pressing to separate cocoa butter and powder, conching (mixing at elevated temperatures for hours), addition of sugar/milk/fats, tempering and molding, and final packaging.

Each processing stage progressively reduces the bioactive compound profile that research associates with metabolic and satiety benefits. The alkaline treatment (Dutching) is particularly significant—while it improves flavor by reducing astringency and darkens color for consumer appeal, it substantially reduces flavanol content through pH manipulation.

Research examining this progressive degradation found that conventional chocolate processing substantially reduces bioactive compounds compared to minimally processed cacao. This explains why grocery store chocolate consumption doesn’t produce the outcomes observed in research studies using minimally processed cacao.

Ceremonial-Grade Processing Preservation Claims

According to Earth Echo Foods’ product positioning, Cacao Bliss uses sun-dried cacao processing that maintains compounds closer to raw cacao levels rather than high-heat roasting. The company positions this processing approach as preserving naturally occurring antioxidant content and bioactive compounds that conventional manufacturing reduces.

Sun-drying involves slow moisture removal at ambient temperatures (typically under 120°F) over extended periods rather than rapid high-heat roasting. This temperature control theoretically preserves heat-sensitive compounds like flavanols while still removing moisture necessary for shelf stability and food safety.

Consumer Verification Questions

When evaluating any chocolate-based supplement claiming superior processing, consumers should verify:

Does the company specifically disclose processing temperature ranges? Vague “low-heat” claims without numbers prevent verification. Does the company explain whether alkaline treatment (Dutching) is used? This detail significantly impacts compound preservation. Can the company provide third-party testing documentation confirming compound content? Claims require verification. How does the product’s antioxidant content compare to raw cacao baselines? Without comparative data, “ceremonial-grade” remains marketing language rather than verifiable differentiation.

Why This Processing Distinction Matters for Weight Management

The processing method question directly relates to weight management outcomes because the compounds potentially affected—flavanols, polyphenols, theobromine, and others—represent the same bioactive components examined in metabolic research. If conventional processing destroys substantial portions of these compounds, then conventional chocolate products would contain insufficient amounts to produce research-observed effects.

This provides theoretical justification for premium processing positioning: if research used minimally processed cacao and observed metabolic effects, then commercial products should preserve those compounds to align with research contexts. However, this logical framework doesn’t constitute proof that any specific product produces weight loss outcomes—it merely explains the rationale behind processing-focused positioning.

Safety Considerations and When to Consult Healthcare Providers

Before evaluating whether any chocolate-based supplement aligns with individual circumstances, consumers must understand safety parameters and situations requiring professional medical consultation.

General Safety Profile and Tolerance Considerations

Cacao-based supplements using quality ingredients are generally well-tolerated by most healthy adults when consumed at recommended dosages. However, several considerations warrant attention:

Stimulant Sensitivity: Cacao contains theobromine, a methylxanthine compound chemically related to caffeine but producing milder, longer-lasting effects. Individuals sensitive to any stimulant compounds—those who experience jitters from coffee, anxiety from green tea, or sleep disruption from afternoon caffeine—should evaluate tolerance carefully.

Digestive Response: Some individuals report mild digestive changes when introducing MCT oil, particularly if consuming higher amounts than their systems typically process. This usually resolves within several days as digestive systems adapt, but sensitive individuals may prefer gradual introduction.

Allergic Reactions: While rare, any food ingredient carries potential for allergic response in susceptible individuals. Consumers with known allergies to any listed ingredients should avoid the product entirely.

Medication Interactions Requiring Professional Consultation

Several situations require healthcare provider consultation BEFORE starting any chocolate-based supplement:

People who are pregnant or nursing, managing a medical condition, scheduled for a procedure, or taking prescription medications should ask a licensed clinician before using any supplement. If adverse reactions occur, stop use and seek medical advice.

Specific Considerations:

Blood Sugar Management: Cinnamon has documented effects on glucose metabolism. Individuals taking medications for blood sugar management should consult healthcare providers before supplementing with cinnamon-containing products.

Blood Thinners: Turmeric has mild blood-thinning properties. Individuals taking anticoagulant or antiplatelet medications should consult healthcare providers before adding turmeric supplementation.

Liver or Kidney Disease: Individuals with compromised liver or kidney function should consult healthcare providers before supplementing with concentrated compounds that require hepatic or renal processing.

Stimulant Sensitivity: Cacao contains theobromine, a methylxanthine compound. Individuals sensitive to stimulant compounds should evaluate tolerance carefully.

Medical Treatment Context

This analysis must emphasize clearly: Cacao Bliss is a dietary supplement, not a medical treatment. Consumers currently under medical care for metabolic conditions, cardiovascular health concerns, diabetes, or weight-related medical issues should NOT alter, reduce, or discontinue prescribed treatments based on supplement use.

Dietary supplements support overall wellness programs but cannot replace medical interventions when clinical care is indicated. Healthcare providers should supervise any modifications to medical treatment plans, and supplement use should be disclosed to all treating physicians to ensure comprehensive care coordination.

Supplement Category Limitations

Consumers should understand that dietary supplements cannot legally claim to treat, cure, or prevent diseases, function as nutritional support not pharmaceutical interventions, work optimally within comprehensive wellness programs, and require realistic expectations about outcome magnitude and timeframe.

Potential Side Effects and Adverse Reactions

While generally well-tolerated, possible reactions include digestive discomfort (rare, typically relates to MCT oil in sensitive individuals), stimulant effects (theobromine may cause mild wakefulness if consumed late evening), and allergic reactions (rare, but any food ingredient carries allergy potential).

Discontinue use and consult healthcare providers if adverse reactions occur.

Individual Response Variability

Even among healthy adults without contraindications, individual responses to any supplement vary dramatically based on genetic factors influencing nutrient metabolism, baseline metabolic rate and hormone levels, age and physiological changes (particularly perimenopause and menopause), current medication use even for unrelated conditions, overall dietary patterns and nutrient status, physical activity levels and types, sleep quality and duration, stress management and cortisol patterns, gut microbiome composition affecting nutrient absorption, and numerous other biochemical and lifestyle variables.

This variability explains why some consumers report substantial benefits while others experience minimal effects despite identical product use and similar starting circumstances. No supplement—regardless of ingredient quality or research foundation—produces uniform results across all individuals.

Questions Readers Often Consider Before Trying a Chocolate-Based Supplement

Rather than suggesting whether any product is a fit, this section lists common considerations readers discuss with clinicians and reflect on personally when evaluating chocolate-based weight management supplements.

Do I genuinely enjoy chocolate flavor enough for consistent daily consumption? Research-aligned usage patterns examined cacao consumption over 8-12 weeks minimum. Daily adherence requires authentic taste preference rather than forced compliance.

Am I prepared to integrate this into comprehensive lifestyle approaches? Research contexts examining cacao and weight loss included structured nutrition approaches and physical activity alongside cacao consumption, not supplement-only protocols.

What are my expectations regarding timeline and magnitude of results? Research studies typically measured outcomes at 8-12 week intervals with average reductions in the 5-7 pound range for participants following comprehensive programs. Individual responses vary dramatically.

Do I have any health conditions or take medications requiring consultation? Blood sugar medications, anticoagulants, and several other prescription categories may interact with supplement ingredients. Healthcare provider consultation remains essential before starting any supplement regimen.

Can I afford ongoing supplementation within my wellness budget? Premium processing methods and organic certification typically correlate with higher per-serving costs compared to conventional supplement categories. Long-term financial sustainability matters for consistent use.

Am I seeking dietary support or clinical-grade intervention? Research demonstrates cacao influences metabolic pathways, but individuals with BMI over 30 or significant health concerns should consult healthcare providers about appropriate intervention levels.

Do I understand that individual results vary substantially? Factors including age, baseline metabolic rate, hormonal status, medication use, genetic factors, sleep quality, stress levels, and numerous other variables create outcome unpredictability that no marketing can overcome.

Have I verified current company policies and ingredient specifications? All supplement companies can modify formulations, pricing, and policies. Independent verification of current terms protects against relying on outdated information.

How to Verify Company Claims, Current Terms, and Product Details

Independent verification protects consumers from relying exclusively on marketing claims or third-party interpretations. This section outlines verification methodology applicable to any supplement purchase decision.

Accessing Official Company Information

Earth Echo Foods maintains official contact channels that consumers can use to verify current policies, ingredient specifications, and company standing:

Phone: 1-888-997-3851 (Customer support line) Email: support@earthechofoods.com Physical Headquarters: Boulder, Colorado (Corporate location details available on company website)

The availability of multiple verifiable contact methods represents one indicator when evaluating company legitimacy. Quality supplement manufacturers typically provide accessible communication channels rather than hiding contact information.

What Current Information Consumers Should Verify Independently

Before making any supplement purchase decision, consumers should independently confirm the following details directly from official company sources, as all terms, pricing, and policies are subject to change without notice:

Current ingredient label specifications and amounts, processing method claims and third-party testing availability, posted company policies regarding returns and refunds, exact timeframes and conditions for any satisfaction guarantee offered, shipping timelines and costs and international availability if relevant, current promotional terms or pricing structures or discount availability.

This verification should occur at the time of potential purchase rather than relying on information from any analysis published previously, as supplement companies frequently modify terms, pricing, and promotional structures.

Company Legitimacy Evaluation Criteria

When evaluating any supplement company, consumers benefit from systematic assessment methodology:

Ingredient Disclosure Standards: Reputable companies provide complete ingredient lists with specific amounts. Proprietary blends that hide formulation details prevent consumers from evaluating dosage adequacy or comparing products across manufacturers.

Third-Party Testing Accessibility: Quality supplement companies typically conduct independent testing for purity, potency, and contaminant screening. Consumers can inquire whether certificates of analysis are available, though not all companies publish testing documentation publicly.

Return Policy Transparency: Legitimate operations clearly state return policies and refund procedures. Vague language or procedural obstacles to returns often indicate problematic business practices.

Marketing Language Assessment: Companies acknowledging individual outcome variability demonstrate regulatory awareness. Guaranteed weight loss claims or “works for everyone” language typically signals either regulatory ignorance or intentional deception.

Operational History Verification: Companies maintaining market presence over multiple years with verifiable customer bases demonstrate stability that newer operations may lack. Consumers can verify operational history through business registration databases and Better Business Bureau records.

Professional Credential Verification

When companies cite founder or formulator credentials, consumers can independently verify claims through professional networking platforms (LinkedIn), published work (books searchable through retailers and library systems), media appearances (entertainment news archives), and authenticated social media accounts. This verification process distinguishes accurate credentials from fabricated authority claims common in supplement marketing.

Verification Resources for Independent Confirmation

Consumers seeking to verify current company information, ingredient specifications, and posted policies can read more at Earth Echo Foods’ official Cacao Bliss product page where terms should be clearly stated and regularly updated. All pricing and company policies are subject to change and should be confirmed at the time of purchase consideration rather than relying on previously published information.

Frequently Asked Questions About Chocolate-Based Weight Management Supplements

What is Cacao Bliss and how is it different from regular cocoa powder?

Cacao Bliss is a dietary supplement formulated by Earth Echo Foods combining ceremonial-grade cacao with seven additional ingredients (cinnamon, turmeric, piperine, MCT oil, monk fruit, lucuma, Himalayan salt) positioned for synergistic metabolic support. According to the company, the primary difference from grocery store cocoa powder involves processing methods—ceremonial-grade cacao uses sun-drying and low-heat approaches to preserve bioactive compounds, while conventional cocoa powder typically undergoes high-heat roasting and alkaline treatment that research shows reduces antioxidant content substantially. Additionally, Cacao Bliss includes researched metabolic support compounds beyond base cacao.

Is Cacao Bliss FDA approved?

No, and this requires important context: Dietary supplements are not reviewed or approved by the FDA as finished products before market availability. The FDA’s regulatory approach to supplements differs fundamentally from prescription medications. Supplement manufacturers must ensure their products contain what labels claim and are free from contaminants, but the FDA does not evaluate whether supplements are effective or whether marketing claims are substantiated. This applies to all dietary supplements, not just Cacao Bliss specifically. The legally required disclaimer states: “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Does chocolate actually increase GLP-1 levels?

Published research from the journal Nutrition (2020) demonstrated that cacao consumption nearly doubled GLP-1 hormone levels compared to water control groups in a 48-participant study. However, critical context: the study tested cacao-based beverages prepared for research purposes, not commercial products. It measured hormone response over hours, not long-term weight loss outcomes. The magnitude of GLP-1 enhancement differs substantially from prescription GLP-1 medications. Research demonstrates cacao can influence the same satiety hormone pathway targeted by medications, but through natural production enhancement at lower magnitudes rather than synthetic hormone delivery at therapeutic doses.

Can supplements like Cacao Bliss replace prescription GLP-1 medications?

No. While research shows dietary cacao influences GLP-1 production, the magnitude and mechanism differ substantially from pharmaceutical interventions. Prescription GLP-1 medications are drugs that mimic GLP-1 at therapeutic doses, producing pronounced appetite suppression under medical supervision for patients meeting specific clinical criteria. Dietary supplements support natural hormone function but cannot replicate pharmaceutical magnitude effects. Individuals currently prescribed GLP-1 medications should never alter, reduce, or discontinue prescribed treatments based on supplement use without physician guidance and supervision. These represent different categories with different applications.

How long does it take to see weight loss results from chocolate supplements?

Individual timelines vary dramatically based on baseline metabolic rate, age, hormonal status, consistency of use, comprehensive lifestyle factors, and numerous other variables. Research studies examining cacao and weight loss typically measured outcomes at 8-12 week intervals. Some individuals report reduced cravings and improved satiety within days, while scale changes typically emerge over weeks to months if they occur at all. Consumers should understand that supplements support comprehensive wellness programs—results depend on simultaneous attention to nutrition quality, physical activity, sleep adequacy, and stress management, not supplement consumption in isolation. No timeline can be guaranteed due to profound individual variability.

Are there any side effects or safety concerns with chocolate-based supplements?

Cacao-based supplements using quality ingredients are generally well-tolerated by healthy adults, but several considerations warrant attention. Cacao contains theobromine (a mild stimulant)—individuals sensitive to stimulants may experience jitters, anxiety, or sleep disruption if consumed late in the day. Some people report temporary digestive changes when introducing MCT oil. Turmeric has mild blood-thinning properties relevant for individuals taking anticoagulants or scheduled for surgeries. Cinnamon affects glucose metabolism, requiring consultation for individuals taking blood sugar medications. Allergic reactions, while rare, are possible with any food ingredient. Pregnant or nursing individuals should consult healthcare providers before using concentrated supplement formulations. Always disclose supplement use to treating physicians.

What makes ceremonial-grade cacao different from regular chocolate?

The distinction centers on processing methods and bioactive compound preservation. Ceremonial-grade cacao traditionally uses sun-drying at ambient temperatures (typically under 120°F) and minimal processing to preserve naturally occurring flavanols, polyphenols, and other compounds. Conventional chocolate manufacturing involves high-temperature roasting (often 300-450°F), alkaline treatment (Dutching), and extended processing that research shows reduces antioxidant content substantially compared to raw cacao. Research published in The Journal of Agricultural and Food Chemistry documented this progressive compound degradation through each processing stage. The ceremonial-grade positioning claims to maintain bioactive compounds at levels closer to raw cacao baselines, though consumers should verify specific products through third-party testing documentation rather than relying solely on marketing claims.

Is chocolate weight loss supplement use safe for people with diabetes?

This requires healthcare provider consultation before starting any supplement regimen. Several ingredients in chocolate-based formulations have documented effects on glucose metabolism—cinnamon influences blood sugar levels, and compounds in cacao affect insulin sensitivity. For individuals taking medications for blood sugar management, the combination may enhance medication effects and potentially require dosage adjustments under medical supervision to prevent hypoglycemia. Additionally, individuals with diabetes should verify carbohydrate and sugar content in any supplement consumed regularly. Never alter diabetes medication dosages based on supplement use without physician guidance. Healthcare providers should supervise integration of any supplements into diabetes management plans.

How do I know if a chocolate supplement company is legitimate or a scam?

Several legitimacy indicators help consumers differentiate quality companies from problematic operations. Verify these factors: transparent ingredient disclosure listing specific amounts rather than “proprietary blends” hiding formulation details; clear contact information including phone numbers, email addresses, and physical headquarters locations; adequate satisfaction guarantee windows (45-60+ days) allowing genuine evaluation time; realistic marketing language acknowledging individual variability rather than guaranteed outcome promises; third-party testing documentation availability for purity and potency verification; established operating history and verifiable customer base; founder credentials that can be independently confirmed through professional profiles and media appearances. Red flags include hidden contact information, very short or absent guarantee periods, extreme outcome promises, fake authority credentials, and pressure tactics creating false urgency.

Can I take chocolate supplements while pregnant or breastfeeding?

Healthcare providers should guide this decision. While dietary chocolate in moderate amounts is generally considered safe during pregnancy and lactation, concentrated supplement formulations containing multiple ingredients have not been adequately studied in pregnant or nursing populations. Insufficient safety data exists for ceremonial cacao supplementation during these life stages. Some ingredients like turmeric have traditional use restrictions during pregnancy in certain dosage ranges. The stimulant content from theobromine, while milder than caffeine, still warrants consideration. Conservative medical guidance typically recommends avoiding supplements without established safety profiles during pregnancy and nursing unless specific benefits outweigh unknown risks under healthcare provider supervision.

What’s the difference between taking a chocolate supplement and just eating dark chocolate?

Several distinctions matter: processing method differences affect bioactive compound content—ceremonial-grade supplements claim to preserve compounds that conventional chocolate manufacturing destroys through high-heat roasting and alkaline treatment. Research shows conventional dark chocolate retains only a portion of raw cacao’s antioxidant capacity. Caloric density differs substantially—chocolate supplements typically provide 30-50 calories per serving versus 150-200+ calories for equivalent flavor satisfaction from conventional chocolate bars. Sugar content varies dramatically—quality supplements use zero-calorie natural sweeteners like monk fruit, while conventional dark chocolate contains processed sugars even in high-percentage cacao bars. Additional ingredients in formulated supplements (cinnamon, turmeric, MCT oil) provide metabolic support compounds absent in plain chocolate. However, cost per serving also differs—supplements typically cost more than conventional chocolate on a per-serving basis.

Do I still need to diet and exercise if I’m taking a chocolate weight loss supplement?

Yes, absolutely. Research examining cacao and weight loss included comprehensive lifestyle protocols—participants followed structured nutrition plans and exercise programs alongside cacao consumption. Studies did not test supplement-only approaches divorced from other health behaviors. Supplements support wellness programs but cannot override poor lifestyle choices or compensate for inadequate nutrition, insufficient activity, poor sleep quality, or unmanaged stress. The research-aligned approach involves daily supplement use PLUS whole-food nutrition emphasis PLUS regular physical activity PLUS adequate sleep PLUS stress management practices. Consumers expecting significant weight loss from supplement consumption alone without lifestyle integration will likely experience disappointing outcomes. View supplements as supporting comprehensive approaches, not replacing fundamental health behaviors.

Source Information and Additional Resources

Primary Product Information:

For current ingredient labels, pricing details, company policies, and posted terms, consumers should review Earth Echo Foods’ official Cacao Bliss product page. Readers seeking to verify information presented in this analysis can access the official product page where complete disclosures should be available.

Company Contact Information:

Earth Echo Foods Boulder, Colorado Customer Support Phone: 1-888-997-3851 Customer Support Email: support@earthechofoods.com

(Readers should verify current contact details on official Earth Echo Foods pages.)

Research Citations Referenced in This Analysis:

This analysis referenced published research from multiple sources including studies published in the journal Nutrition (2020) examining GLP-1 hormone response to cacao consumption, research from the University of California San Diego School of Medicine examining weight loss outcomes with cacao protocols, studies from Cairo University examining cinnamon’s influence on glucose metabolism, research from the State University of New York School of Medicine exploring curcumin’s potential effects on adipose inflammation, studies from Columbia University and King’s College London examining MCT oil’s influence on satiety hormones, and research published in The Journal of Agricultural and Food Chemistry documenting compound degradation through conventional chocolate processing.

Consumers interested in examining original research should search academic databases using author names, institution affiliations, and publication details to access primary sources rather than relying exclusively on summaries or marketing interpretations.

Independent Verification Resources:

For consumers seeking to verify supplement quality claims independently:

ConsumerLab.com provides independent testing results for supplements, including product quality verification and label accuracy assessment (subscription required for full access).

Labdoor offers independent supplement testing and quality grading based on label accuracy, nutritional value, ingredient safety, and projected efficacy.

NSF International and USP (United States Pharmacopeia) provide third-party certification programs for supplements meeting specific quality and purity standards (consumers can search certified product databases).

National Institutes of Health Office of Dietary Supplements provides evidence-based information about dietary supplement ingredients, safety considerations, and research contexts at ods.od.nih.gov.

Disclaimers

Editorial Disclaimer: This consumer analysis is for informational purposes only and does not constitute medical advice, diagnosis, treatment recommendations, or professional health guidance. Weight management concerns should be evaluated by qualified healthcare professionals. Always consult a qualified healthcare professional before starting any new supplement regimen, particularly if taking medications, managing existing health conditions, or if pregnant or nursing. This analysis does not evaluate clinical efficacy or determine which products are objectively “best” as individual needs vary.

Dietary Supplement Notice: Cacao Bliss is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not reviewed or approved by the FDA as finished products before market availability.

Results May Vary: Individual weight loss results vary significantly based on factors including age, baseline health condition, metabolic rate, hormonal status, consistency of use, genetic factors, current medications, physical activity levels, overall dietary patterns, sleep quality, stress management, and numerous other individual variables. While some consumers report weight management benefits, results are not guaranteed. Research findings from controlled studies may not translate directly to individual supplement use in uncontrolled real-world conditions.

Professional Medical Disclaimer: This analysis is educational and does not constitute medical advice or professional health guidance. Cacao Bliss is a dietary supplement, not a medication or medical treatment. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting Cacao Bliss or any new supplement. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician’s guidance and approval. Healthcare providers should supervise any modifications to medical treatment plans.

Medication Interaction Considerations: Individuals taking medications for blood sugar management should exercise particular caution, as cinnamon’s documented effects on glucose metabolism may necessitate medication dosage adjustments under healthcare provider supervision. Individuals taking blood thinners or anticoagulants should consult healthcare providers before supplementing with turmeric due to mild blood-thinning properties.

Affiliate Disclosure: This article contains affiliate links. If purchases are made through these links, commissions may be earned at no additional cost to consumers. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on published research, publicly available company information, and established evaluation criteria.

Pricing and Terms Disclaimer: All prices, discounts, guarantee terms, and promotional offers mentioned were accurate at the time of publication (January 2, 2026) but are subject to change without notice. Always verify current pricing, terms, policies, and promotional offers on official Earth Echo Foods channels before making purchase decisions. This analysis does not guarantee current availability or specific pricing.

Publisher Responsibility Disclaimer: The publisher of this analysis has made every effort to ensure accuracy at the time of publication based on available research, company materials, and industry standards. We do not accept responsibility for errors, omissions, or outcomes resulting from use of the information provided. Consumers are encouraged to verify all details directly with Earth Echo Foods and their healthcare providers before making decisions.

Research Context Disclaimer: Research studies cited examine cacao compounds, minimally processed cacao consumption, or specific ingredient effects in controlled settings. Study results do not guarantee identical outcomes with supplement use. Research contexts differ from real-world application in numerous ways including dosage standardization, participant selection criteria, controlled environments, comprehensive monitoring, and defined study durations. Individual supplement responses vary and may differ substantially from research findings. No research cited specifically evaluated Earth Echo Foods’ Cacao Bliss product.

Contact Information Disclaimer: All contact information, policies, shipping terms, satisfaction guarantees, and company details were accurate as of January 2, 2026 publication date but remain subject to change without notice. Consumers should verify current information on official company channels before purchasing or seeking support.

Testimonial and Customer Experience Disclaimer: Any customer testimonials or reported experiences referenced represent individual outcomes and are not typical results. Individuals providing testimonials may have received free products or compensation in exchange for honest reviews. Results vary based on numerous individual factors. Testimonials reflect opinions of specific customers and do not represent guarantees of similar outcomes for all consumers.

Regulatory Context Disclaimer: The dietary supplement industry faces ongoing regulatory discussion and oversight evolution. Consumers should understand that supplements receive less stringent pre-market oversight than pharmaceutical products. Reputable companies invest in third-party testing, transparent sourcing, and quality manufacturing practices, but verification remains the consumer’s responsibility.

For personalized guidance on weight management strategies, metabolic health optimization, dietary supplement evaluation, or comprehensive wellness program development, consumers should consult qualified healthcare professionals, registered dietitians, or certified wellness practitioners who can provide individualized recommendations based on complete health histories, current medications, and specific goals.

Contact: Earth Echo Foods Email: support@earthechofoods.com Phone: 1-888-997-3851 (Readers should verify current contact details on official Earth Echo Foods pages.)

This is a consumer analysis summarizing publicly available information for informational purposes only. This consumer analysis was published January 2, 2026, and reflects information accurate as of that date. All research citations, company claims, and policy details should be independently verified on current official sources before making purchasing decisions.

CONTACT: Email: support@earthechofoods.com 
Phone: 1-888-997-3851

Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain

Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain




Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain

Clinic’s consistent 4.7-star rating reflects nearly four decades of patient trust, care quality, and international recognition in the field of aesthetic surgery

Zaragoza, Aragón, Jan. 02, 2026 (GLOBE NEWSWIRE) — Clínica García-Dihinx, a leading plastic surgery clinic in Zaragoza, Spain, is proud to announce that it has reached a new milestone: more than 500 public reviews on Google Maps, maintaining a strong average rating of 4.7 out of 5. This accomplishment is a reflection of nearly 40 years of sustained dedication to patient care, surgical excellence, and personalized treatment experiences.

Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain

Plastic surgery clinic in Zaragoza, Spain offering aesthetic and reconstructive procedures to local and international patients.

The milestone comes at a time when online reviews play a decisive role in how patients select medical providers—especially for international patients considering aesthetic procedures in Spain. The clinic’s verified reputation through public feedback reinforces its position as a trusted and highly rated provider in the field of cosmetic and reconstructive surgery.

“This is more than a number—it’s a recognition of the relationships we’ve built with patients over decades,” said Dr. García-Dihinx, medical director of the clinic. “Every review tells part of a real experience, and we value each one as part of our ongoing commitment to quality, transparency, and patient safety.”

Founded more than 38 years ago, Clínica García-Dihinx has continuously evolved to meet the expectations of a diverse and international patient base. The clinic offers a wide range of aesthetic and reconstructive treatments performed by a multidisciplinary medical team with expertise in modern, minimally invasive, and patient-tailored surgical methods. Its focus on ethical medical practice, post-surgical follow-up, and clear communication has earned the trust of thousands of patients over the years.

Among the most commonly cited aspects in patient reviews are:

  • The professionalism and empathy of the medical team
  • High standards of surgical care and hygiene
  • Attention to individual goals and expectations
  • Clear pre- and post-operative communication
  • Consistent outcomes with natural aesthetic results

The clinic’s visibility and reliability among both local and international audiences are supported by its official online presence. Visitors to garcia-dihinx.com can access detailed information about procedures, medical protocols, safety standards, and real patient stories. In addition, educational material and behind-the-scenes content are available on the clinic’s YouTube channel.

“Transparency and continuous improvement are core values here,” added the clinic’s management team. “By listening to patient feedback, we’ve been able to refine protocols and maintain high satisfaction rates. Our reviews help guide us in improving not just results, but also the overall experience.”

As the demand for medical tourism in Spain continues to rise, particularly in plastic surgery, patients are turning to trusted sources like Google to validate their options. The clinic’s consistent stream of verified, detailed, and positive reviews offers a reliable resource for those exploring surgery abroad.

With this 500-review milestone, Clínica García-Dihinx reaffirms its ongoing mission to provide a safe, ethical, and results-driven approach to plastic surgery, while remaining accessible and transparent to both local residents and international visitors.

For more information about treatments, medical team profiles, or to read patient testimonials, visit garcia-dihinx.com or view the clinic’s public profile on Google Maps.

Clínica García-Dihinx Celebrates 500 Google Reviews Milestone, Reinforcing Its Role as a Leading Plastic Surgery Clinic in Zaragoza, Spain

Clinic specializing in cosmetic surgery and patient-focused treatments, with a reputation for quality care in Spain.

About Clínica García-Dihinx

Clínica García-Dihinx is a plastic surgery clinic in Zaragoza, Spain, specializing in aesthetic and reconstructive procedures. With over 38 years of experience, the clinic is recognized for its commitment to ethical medical practice, personalized care, and surgical excellence.

Press Inquiries

Clínica García-Dihinx
https://garcia-dihinx.com/
Guillermo Suils
prensa@garcia-dihinx.com
+34 657 53 34 14

A video accompanying this announcement is available here: https://youtube.com/watch?v=jntsvuEyyVg

Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules




Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules

NEW YORK, Jan. 02, 2026 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced private placement with two healthcare focused institutional investors priced at-the-market under Nasdaq rules of 2,298,850 shares of common stock (or pre-funded warrants in lieu thereof), Series K-1 warrants to purchase up to an aggregate of 2,298,850 shares of common stock and Series K-2 warrants to purchase up to an aggregate of 2,298,850 shares of common stock, at a combined purchase price of $4.35 per share of common stock (or pre-funded warrant) and associated Series K-1warrants and Series K-2 warrants, for expected gross proceeds to INBS of approximately $10.0 million, before deducting placement agent fees and other offering expenses payable by the Company. The Series K-1warrants and Series K-2 warrants will have an exercise price of $4.10 per share of common stock and will be exercisable immediately upon issuance. The Series K-1 warrants and Series K-2 warrants will each have a term of five years following the date a registration statement registering all warrant shares underlying the Series K-1 warrants and Series K-2 warrants is declared effective by the United States Securities and Exchange Commission (the “SEC”).

Harry Simeonidis, President and CEO of INBS, commented, “We welcome the continued support from our investors as we intend to use the proceeds of this private placement for working capital and general corporate purposes, including funding our 510(k) submission with the FDA for our non-invasive Intelligent Fingerprinting Drug Screening System and furthering our international market expansion.”

Ladenburg Thalmann & Co. Inc. acted as the exclusive placement agent for the private placement.

The offer and sale of the foregoing securities were made in a transaction not involving a public offering and the securities have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Under an agreement with the investors, the Company agreed to file an initial registration statement with the SEC covering the resale of the shares of common stock issued to the investors (including the shares of common stock issuable upon the exercise of the warrants) no later than 10 calendar days following the date of the agreement and to use its best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 45 days after the date of such agreement.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. 

About Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.

For more information, visit: http://www.ibs.inc/.

Forward-Looking Statements:

Some of the statements in this release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, Intelligent Bio Solutions Inc.’s intended use of proceeds from the private placement, ability to develop and commercialize its drug and diagnostic tests, realize commercial benefit from its partnerships and collaborations, and secure regulatory approvals, among others. Although Intelligent Bio Solutions Inc. believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Intelligent Bio Solutions Inc. has attempted to identify forward-looking statements by terminology, including “believes,” “estimates,” “anticipates,” “expects,” “plans,” “projects,” “intends,” “potential,” “may,” “could,” “might,” “will,” “should,” “approximately” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, included in Intelligent Bio Solutions’ public filings filed with the Securities and Exchange Commission. Any forward-looking statements contained in this release speak only as of its date. Intelligent Bio Solutions undertakes no obligation to update any forward-looking statements contained in this release to reflect events or circumstances occurring after its date or to reflect the occurrence of unanticipated events.

Company Contact:

Intelligent Bio Solutions Inc.
info@ibs.inc

Investor & Media Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com